Institut Jules Bordet

Brussels (Belgium be)
Oncology

Bibliometric indicators

Evolution over the last years of activity

Showing the period - Sept. 2024

8,145
Activity
3%

Total documents

2.32
Impact
3%

Normalized Impact

1,383
Excellence
3%

Highly Cited Papers (Top 10%)

75.9
Leadership
3%

Leadership (%)

53.5
Mobility & Collaboration
3%

International Collaboration (%)

257
Excellence
3%

Outstanding papers (Top 1%)

16.2
Leadership
3%

Women Leading (%)

7.9
Leadership
3%

Women Leading International (%)

40.1
Open Access
3%

Open Access (%)

Main Research Fields (top 9 by publications)

Indicators:

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Human Resources

Historical perspective

From to Sept. 2024

Current resources

Quick filters

Career Stage
Occasional Junior Researcher Senior Leading
Performance
Standard Good Excellent Outstanding
Gender
Male Female
Reset
0

Personnel

0.0

Papers / Personnel

0

Leading women (%)

0
0

Gender (%)

0

Papers / Permanent researchers

0

Papers / Leading researchers

Career stage

Performance

Years of Activity

ONE Index (distribution)

ONE Index by Main Research Fields

ONE Index vs. Years of Activity

Main authors

ID Name Gender Discipline Career Stage ONE Index Years Activity NDocs RCI HCP Leader Collab.
1 Sotiriou, Christos male Oncology, Cancer Research Leading researcher 918 30 777 3.96 182 37.1% 51.9%
2 Desmedt, Christine female Oncology, Cancer Research Senior researcher 909 31 455 4.69 110 30.1% 57.6%
3 Piccart, Martine male Oncology Leading researcher 896 49 1,347 3.64 306 38.5% 50.9%
4 de Azambuja, Evandro female Oncology Senior researcher 881 23 564 3.43 115 32.1% 68.8%
5 Ignatiadis, Michail male Oncology Researcher 880 29 220 2.72 57 40.0% 55.9%
6 Azim, Hatem male Oncology Senior researcher 873 19 204 3.18 45 54.4% 69.6%
7 Larsimont, denis male Oncology Leading researcher 864 36 515 3.12 101 9.7% 36.7%
8 Buisseret, Laurence male Oncology Senior researcher 837 16 123 2.34 21 30.9% 59.4%
9 Aftimos, Philippe male Oncology Senior researcher 835 16 232 2.47 36 24.6% 63.4%
10 Flamen, Patrick male Radiology, Nuclear Medicine and Imaging Leading researcher 833 37 297 1.73 55 41.1% 19.9%
11 Ahmad male Oncology Leading researcher 830 43 831 1.41 102 39.7% 44.4%
12 Hendlisz, Alain male Oncology Leading researcher 827 32 422 2.50 65 23.5% 32.0%
13 Willard-Gallo, Karen female Oncology, Immunology Leading researcher 821 46 258 1.80 43 48.1% 32.6%
14 Agostinetto, Elisa female Oncology Researcher 814 10 116 1.62 19 30.2% 65.5%
15 Sclafani, Francesco male Oncology Senior researcher 813 17 200 1.17 29 56.0% 36.5%
16 ║ Jean‐Paul Sculier Pulmonary and Respiratory Medicine Leading researcher 812 44 600 1.70 59 75.5% 12.7%
17 Bareche, Yacine female Oncology, Cancer Research Researcher 806 9 48 2.26 11 18.8% 62.5%
18 Ameye, Lieveke male Oncology Senior researcher 798 27 348 1.71 57 9.8% 45.4%
19 Bron, Dominique female Genetics, Hematology, Oncology Leading researcher 797 47 597 1.36 74 35.5% 23.1%
20 Caparica, Rafael male Oncology Researcher 796 9 47 1.33 6 44.7% 85.1%
21 Meuleman, Nathalie female Molecular Biology, Genetics, Hematology Senior researcher 787 25 154 3.13 38 11.0% 38.3%
22 Laurence, Lagneaux male Genetics Leading researcher 786 39 175 1.84 34 50.3% 31.4%
23 Solinas, Cinzia female Oncology Senior researcher 783 24 106 1.64 20 43.4% 57.6%
24 Donckier, Vincent male Surgery Leading researcher 782 33 229 1.25 27 41.1% 16.2%
25 Gebhart, géraldine female Radiology, Nuclear Medicine and Imaging Researcher 779 14 49 2.86 12 38.8% 63.3%
918
One Index
Sotiriou, Christos PhD   0000-0002-5745-9977 777 docs (1995 - 2024)  
Breast Cancer , Cancer Genomics , Triple-negative breast cancer , Intratumor Heterogeneity , Tumor Microenvironment
909
One Index
Desmedt, Christine PhD   0000-0002-5223-5579 455 docs (1994 - 2024)  
Breast Cancer , Cancer Genomics , Tumor Microenvironment , Intratumor Heterogeneity , Tumor-infiltrating lymphocytes
896
One Index
Piccart, Martine PhD   0000-0001-9068-8504 1347 docs (1976 - 2024)  
Breast Cancer , Trastuzumab , Metastatic Breast Cancer , Lapatinib , HER2
881
One Index
de Azambuja, Evandro PhD   0000-0001-9501-4509 564 docs (2002 - 2024)  
Breast Cancer , Lapatinib , Trastuzumab , HER2 , Neoadjuvant Therapy
880
One Index
Ignatiadis, Michail PhD   0000-0002-4493-3748 220 docs (1996 - 2024)  
Breast Cancer , Circulating tumor cell , Cancer Genomics , Gene Expression , Tumor Evolution
873
One Index
Azim, Hatem PhD   0000-0003-4865-3193 204 docs (2006 - 2024)  
Breast Cancer , Pregnancy , Gene Expression , Gene Set Enrichment Analysis , Profiling (computer programming)
864
One Index
Larsimont, denis PhD   0000-0003-2152-253X 515 docs (1989 - 2024)  
Tumor Microenvironment , Breast Cancer , Tumor-infiltrating lymphocytes , Intratumor Heterogeneity , Cancer Genomics
837
One Index
Buisseret, Laurence PhD   0000-0002-3751-0819 123 docs (2009 - 2024)  
Triple-negative breast cancer , Tumor Microenvironment , Differential effects , Tumor-infiltrating lymphocytes , Triple negative
835
One Index
Aftimos, Philippe PhD   0000-0001-9946-4726 232 docs (2009 - 2024)  
Breast Cancer , Metastatic Breast Cancer , Fulvestrant , PET Imaging , Clinical endpoint
833
One Index
Flamen, Patrick PhD   0000-0003-2193-6599 297 docs (1988 - 2024)  
PET/CT , Cancer Imaging , PET Imaging , Metastatic Colorectal Cancer , Tumor Heterogeneity
830
One Index
Ahmad PhD   0000-0001-7412-9163 831 docs (1982 - 2024)  
Breast Cancer , Metastatic Breast Cancer , Clinical endpoint , Pharmacodynamics , Microtubule-Targeting Agents
827
One Index
Hendlisz, Alain PhD   0000-0003-2122-1948 422 docs (1993 - 2024)  
Metastatic Colorectal Cancer , Clinical endpoint , Cancer Imaging , Mitoxantrone , Regorafenib
821
One Index
Willard-Gallo, Karen PhD   0000-0002-1150-1295 258 docs (1979 - 2024)  
Tumor Microenvironment , Tumor-infiltrating lymphocytes , Cancer Immunoediting , Biomarkers for Immunotherapy , CXCL13
814
One Index
Agostinetto, Elisa PhD   0000-0003-0295-7511 116 docs (2015 - 2024)  
Breast Cancer , Metastatic Breast Cancer , Triple-negative breast cancer , HER2 , CDK4/6 Inhibitors
813
One Index
Sclafani, Francesco PhD   0000-0003-0251-2627 200 docs (2008 - 2024)  
Metastatic Colorectal Cancer , Neoadjuvant Therapy , Chemoradiotherapy , Regorafenib , Clinical endpoint
812
One Index
║ Jean‐Paul Sculier PhD 600 docs (1981 - 2022)  
Non-Small Cell Lung Cancer , Small-Cell Lung Cancer , Lung Cancer , Tumor Staging , Biomarker Analysis
806
One Index
Bareche, Yacine PhD   0000-0002-7208-6494 48 docs (2016 - 2024)  
Table (database) , Hormone Receptors , Gene Expression , Prognostic Markers , Tumor Microenvironment
798
One Index
Ameye, Lieveke PhD   0000-0001-5153-1766 348 docs (1998 - 2024)  
Breast Cancer , Tumor Models , Maternal Weight Gain , Biglycan , Adnexal mass
797
One Index
Bron, Dominique PhD   0000-0002-1634-1104 597 docs (1978 - 2024)  
Mesenchymal Stem Cells , Stromal Cells , Cancer in Older Adults , Geriatric Assessment , Cord blood
796
One Index
Caparica, Rafael PhD   0000-0001-5573-0711 47 docs (2016 - 2024)  
Breast Cancer , Metastatic Breast Cancer , Neoadjuvant Therapy , HER2 , Clinical endpoint
787
One Index
Meuleman, Nathalie PhD   0000-0003-0479-2474 154 docs (2000 - 2024)  
International Myeloma Working Group , Mesenchymal Stem Cells , Stromal Cells , Refractory (planetary science) , Melphalan
786
One Index
Laurence, Lagneaux PhD   0000-0002-9190-0682 175 docs (1986 - 2024)  
Mesenchymal Stem Cells , Stromal Cells , Cell therapy , Regenerative medicine , Cytomegalovirus
783
One Index
Solinas, Cinzia PhD   0000-0001-6782-8708 106 docs (2001 - 2024)  
Tumor Microenvironment , Tumor-infiltrating lymphocytes , Cancer Immunoediting , Biomarkers for Immunotherapy , Immune checkpoint
782
One Index
Donckier, Vincent PhD   0000-0003-1457-2520 229 docs (1992 - 2024)  
Indocyanine green , Liver Transplantation , Living Donor Liver Transplantation , Immunosuppression , Surgical oncology
779
One Index
Gebhart, géraldine PhD   0000-0001-8853-0783 49 docs (2011 - 2024)  
PET/CT , PET Imaging , Breast Cancer , Pertuzumab , Trastuzumab